eloralintide vs retatrutide Lilly's Amylin Agonist Outperforms Novo's Cagrilintide at 48 Weeks Retatrutide vs Eloralintide Obesity Therapies

117,122,123 A Staged Therapeutic Recommendation GLP-1 RA-MWL requires a multistep treatment plan that addresses each component of aging

The most frequently dispensed medications to incident GLP-1 RA patients, dispensed at least once in the 24-month period before the first GLP-1 RAs, were antihypertensives (64.8%), followed by another antidiabetic drug (61.3%)

Patients who are generally metabolically healthy but require intervention for obesity or overweight

Hormone variations (menstrual cycle, menopause status) can create weekly fluctuations in women that are less apparent in men, but total trajectory by week 48 is similar between genders